New & Emerging Treatments
The New & Emerging Treatments webinar series is hosted annually by the Leukemia Research Foundation for leukemia patients, caregivers, family members, and healthcare professionals. Each hour-long program is dedicated to a specific subtype of leukemia, and addresses the latest treatments, ongoing research, and what's on the horizon, followed by a live Q & A.
Acute lymphocytic leukemia (ALL)
FEBRUARY 23, 2026 I 12:00-1:00PM CT (10:00 PT, 11:00 MT, 1:00 ET)
Jae Park, MD, Chief, Cellular Therapy Service, ALL Specialist, Professor of Medicine, Memorial Sloan Kettering Cancer Center, discusses current ALL treatments and what new treatments are on the horizon.
Acute myeloid leukemia (AML)
FEBRUARY 23, 2026 I 1:00-2:00pm CT (11:00 PT, 12:00 MT, 2:00 ET)
Eunice Wang, MD, Chief, Leukemia Service and Professor, Roswell Park Comprehensive Cancer Center, addresses current AML treatments and shares what new treatments are on the horizon.
Chronic lymphocytic leukemia (CLL)
FEBRUARY 24, 2026 I 12:00PM-1:00PM CT (10:00 PT, 11:00 MT, 1:00 ET)
Ryan Jacobs, MD, Director, Lymphoma Section, Atrium Health Levine Cancer Institute, Associate Professor, Division of Cancer Medicine, Wake Forest University School of Medicine, discusses current CLL treatments and what new treatments are on the horizon.
Chronic myeloid leukemia (CML)
FEBRUARY 25, 2026 I 12:00PM-1:00PM CT (10:00 PT, 11:00 MT, 1:00 ET)
Fadi Haddad, MD, Assistant Professor, Department of Leukemia, The University of Texas MD Anderson Cancer Center, addresses current CML treatments and shares what new treatments are on the horizon.
Program supporters
2026 ADVOCATE PARTNER
SUSTAINING SUPPORTERS
SESSION SUPPORTER - AML
